Log in
Enquire now
‌

US Patent 11951216 Polymer protein microparticles

Patent 11951216 was granted and assigned to Regeneron Pharmaceuticals on April, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
0
Date Filed
February 22, 2022
0
Date of Patent
April 9, 2024
0
Patent Applicant
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
0
Patent Application Number
17677282
0
Patent Citations
‌
US Patent 7279159 VEGF inhibitor polypeptides
0
‌
US Patent 6927004 Mask for use in lithography, method of making a mask, lithographic apparatus, and device manufacturing method
0
‌
US Patent 6927044 IL-1 receptor based cytokine traps
0
‌
US Patent 6956021 Stable spray-dried protein formulations
0
‌
US Patent 7087411 Fusion protein capable of binding VEGF
0
‌
US Patent 7279158 Methods for the treatment of inflammatory joint disease
0
‌
US Patent 7303746 Methods of treating eye disorders with modified chimeric polypeptides
0
‌
US Patent 7303747 Use of VEGF inhibitors for treatment of eye disorders
0
‌
US Patent 7365165 IL-1 antagonist formulations
0
‌
US Patent 7374758 Modified chimeric polypeptides with improved pharmacokinetic properties and methods of using thereof
0
•••
Patent Inventor Names
Scott Walsh
0
Hunter Chen
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11951216
0
Patent Primary Examiner
‌
Sarah Alawadi
0
CPC Code
‌
A61K 9/1617
0
‌
A61K 9/1623
0
‌
A61K 9/5031
0
‌
A61K 9/5047
0
‌
A61K 38/179
0
‌
A61K 9/1641
0
‌
A61K 9/1647
0
‌
A61K 9/1652
0
‌
A61K 2039/505
0
‌
A61K 38/00
0
•••

Find more entities like US Patent 11951216 Polymer protein microparticles

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.